Last update 16 May 2024

Ampicillin/Cloxacillin Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Viccillin, Viccillin-S, ビクシリン
Target
PBPs
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors)
Therapeutic Areas
Infectious DiseasesNervous System DiseasesCardiovascular Diseases+ [3]
Active Indication
EndocarditisMeningitisRespiratory Tract Infections+ [5]
Inactive Indication-
Originator Organization
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
Active Organization
Bright Future Pharmaceuticals FactoryMeiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (01 Aug 1970),
Lung AbscessPneumonia
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC19H20ClN3NaO6S
InChIKeyKNNWTOJBVOKDPC-VICXVTCVSA-N
CAS Registry7081-44-9
View All Structures (2)

Related

100 Clinical Results associated with Ampicillin/Cloxacillin Sodium
Login to view more data
100 Translational Medicine associated with Ampicillin/Cloxacillin Sodium
Login to view more data
100 Patents (Medical) associated with Ampicillin/Cloxacillin Sodium
Login to view more data
5
Literatures (Medical) associated with Ampicillin/Cloxacillin Sodium
01 Jul 1996Kyobu geka. The Japanese journal of thoracic surgery
[A case report of an infective endocarditis caused by methicillin-resistant Staphylococcus aureus with successful mitral valve replacement].
01 Jan 1978The Japanese journal of antibiotics
[Therapeutic results of respiratory tract infections treated by intravenous drip with Viccillin S, a combined preparation of synthetic penicillins (author's transl)].
01 Jun 1971The Japanese journal of antibiotics
[Clinical experience with drip infusion of ampicillin-cloxacillin combination (Viccillin S, "Meiji")].
100 Deals associated with Ampicillin/Cloxacillin Sodium
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
J01CA51
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Endocarditis
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Meningitis
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Respiratory Tract Infections
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Sepsis
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Soft Tissue Infections
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Urinary Tract Infections
CN
Bright Future Pharmaceuticals Factory
16 Aug 2012
Lung Abscess
JP
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
01 Aug 1970
Pneumonia
JP
Meiji Seika Pharma Co., Ltd.Meiji Seika Pharma Co., Ltd.
01 Aug 1970
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free